Skip to main content
. 2021 Feb 1;48(2):171–180. doi: 10.1053/j.seminoncol.2021.01.003

Table 4.

Univariate and adjusted analysis of COVID-19 mortality, in the A.C. Camargo Cancer Center, from April to August, 2020, São Paulo – SP, Brazil.

Variables ORa univariate (95% CI) P ORa adjusted (95% CI) P
Histology (ICD-O3)
Other Solid Tumors 1 1
Hematological (C42, C77) 2.40 (1.09–5.24) .029 2.17 (0.96–4.90) .062
Lung (C34) 4.44 (1.56–12.57) .005 4.05 (1.33–12.34) .014
Sex
Female 1 1
Male 0.83 (0.46–1.49) .539 0.88 (0.47–1.66) .709
Age group
<60 1 1
≥60 2.44 (1.31–4.53) .005 2.26 (1.18–4.35) .014
Type of insurance
Public 1 - -
Private 0.83 (0.45–1.53) .548 - -
Situation at diagnosis of COVID-19
In follow-up 1 - -
In treatment 2.38 (1.11–5.09) .024 2.77 (1.25–6.13) .011
Palliative 19.01 (3.69–98.75) .001 17.66 (3.13–99.59) .001

Other Solid Tumors = (C50, C15-C17, C22-C26, C18-C21, C61, C64-C68, C30-C39, C51-C58, C49, C00-C14, C69-C72).

The values in bold are significant.

a

OR = Odds Ratio. Multivariable corrections were made for patient age and sex.